Search Results 751-760 of 15118 for blueberry
Taselisib is a PI3K inhibitor. The PI3K pathway is involved is cancer growth. Androgen may cause the growth of tumor cells. Enzalutamide may stop the growth of ...
About this study. The primary hypothesis is that patients with HFREF (heart failure with reduced ejection fraction) will demonstrate a markedly expanded ...
Dr. Staff's Translational Neuromuscular Disease Research Lab at Mayo Clinic is involved with clinical trials of mesenchymal stem cells (MSCs) in ALS.
Dr. Cliby's research in clinical outcomes focuses on treatment of ovarian cancer with a specific interest in surgical management. Dr. Cliby leads multiple ...
We will develop a multivariable model combining ctDNA and FDG PET/MRI biomarkers to predict treatment response and survival. In addition, we will define the ...
About this study. The purposes of this study are to evaluate whether pre-NAC peripheral blood immune phenotypes (defined by mass cytometry) are associated ...
This trial studies how well two surgical procedures (bilateral salpingectomy and bilateral salpingo-oophorectomy) work in reducing the risk of ovarian cancer ...
The purpose of this study is to determine the feasibility of hippocampal-avoidance (HA) with proton therapy in suprasellar or midline low-grade gliomas (LGGs).
The purpose of this study is to determine whether ornithine phenylacetate can speed recovery from an acute hepatic encephalopathy episode requiring ...
Skip to Content. English. Español · العربية · 简体中文 · Português Br · Journalist Pass · Sign In · Appointments. Search. Request appointment · Sign in.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.